Including

• Navigating a Global Marketplace: Managing the Manufacturing, Sales and Distribution of Drugs and Medical Devices by Being Vigilant of the Latest Anti-Corruption Pitfalls

  Navigating a Global Marketplace 3-2015 - March 2015
  by Parth Chanda, Assistant General Counsel, Anti-Corruption Program at Pfizer Inc, Michael Russell Clarke, VP, Ethics & Compliance – Americas at Actavis, Inc., Katherine DeKam, Chief Compliance Officer – Director of Compliance at Acumed, LLC, Maura K. Monaghan, Partner at Debevoise & Plimpton LLP

• CIAs: What You Need to Consider Before Signing, During Oversight, and What to Expect After Reaching the Finishing Line

  ENFORCEMENT TRENDS TO WATCH IN 2015 - March 2015
  by Jaime L.M. Jones, Partner at Sidley Austin LLP

• CIAs: What You Need to Consider Before Signing, During Oversight, and What to Expect After Reaching the Finishing Line

  CIAs: What You Need to Consider Before Signing, During Oversight, and What to Expect After Reaching the Finishing Line 3-2015 - March 2015
  by Mark P. Goodman, Partner at Debevoise & Plimpton LLP, Jaime L.M. Jones, Partner at Sidley Austin LLP, Paige Slater, Global CIA Program Director at DePuy Synthes

• Lines in the Sand: Extracting Hard Lines from Government Guidance on Social Media

  Panning and Prospecting for Lines in the Sand on Social Media - March 2015
  by Christine Mikail, Senior Vice President, Legal Affairs & General Counsel at NPS Pharmaceuticals, Inc., Elise Fellner Roth, Associate at Buchanan Ingersoll & Rooney PC

• Under the Microscope: Managing, Defending and Curtailing Whistleblowers and Allegations under the False Claims Act

  Identifying Serial Whistleblowers and Working With Relators 3-2015 - March 2015
  by Lisa M. Noller, Partner and Vice-Chair, Government Enforcement and White Collar Criminal Defense Practice at Foley & Lardner, LLP

• Understanding and Adapting to New Guidance Regarding the Parameters of Conversation and Dissemination of Information Regarding Off- Label Use of Medical Devices

  Understanding the Parameters of Conversation and Dissemination of Off-Label Use Information 3-2015 - March 2015
  by Anne K. Walsh, Director at Hyman, Phelps & McNamara PC, Darren W. Alch, Vice President, General Counsel & Compliance Officer at Cyberonics, Inc.

• Navigating the Federal Anti-Kickback Statute and Identifying the Specific Risks for Medical Device Companies

  Selected Kickback Cases 2013-2014 - March 2015
  by Thomas M. Gallagher, Partner at Pepper Hamilton LLP

• Insiders’ Roundtable on Recent Enforcement and Compliance Trends

  Hot Topics: Recent Enforcement and Compliance Trends 3-2015 - March 2015
  by Jacqueline Romero, Assistant United States Attorney at U.S. Department of Justice, Betsy Van Hecke, VP, Legal for the Cardiac and Vascular Group at Medtronic (Mounds View, MN)